PMID- 17374712 OWN - NLM STAT- MEDLINE DCOM- 20070718 LR - 20070607 IS - 0021-972X (Print) IS - 0021-972X (Linking) VI - 92 IP - 6 DP - 2007 Jun TI - Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. PG - 2240-7 AB - CONTEXT: Macrophage infiltration into adipose tissue has been demonstrated to accompany obesity, with a potential preferential infiltration into intraabdominal vs. sc fat. OBJECTIVE: Our objective was to determine whether this occurs across different populations with a range of body mass indexes and to assess the relationship with regional adiposity and comorbidity of obesity. SETTING AND PATIENTS: In two independent cohorts, we used paired omental (OM) and sc fat biopsies from lean controls or predominantly sc or intraabdominally obese persons with minimal comorbidity (n = 60, cohort 1), or from severely obese women with a significant rate of comorbidity (n = 29, cohort 2). RESULTS: Elevated macrophage infiltration into OM vs. sc fat was observable in lean subjects and exaggerated by obesity, particularly if predominantly intraabdominal. This was paralleled by increased monocyte chemoattractant protein-1 (MCP1) and colony-stimulating factor-1 (CSF1) mRNA levels. Level of CSF1 and MCP1 mRNA correlated with the number of OM macrophages (r = 0.521, P < 0.0001 and r = 0.258, P < 0.051, respectively). In severely obese women (mean body mass index = 43.0 +/- 1.1 kg/m(2)), higher protein expression of both MCP1 and CSF1 was detected in OM vs. sc fat. Number of OM macrophages, but not of sc macrophages, correlated with waist circumference (r = 0.636, P = 0.001 vs. r = 0.170, P = 0.427) and with the number of metabolic syndrome parameters (r = 0.385, P = 0.065 vs. r = -0.158, P = 0.472, respectively). Preferential macrophage infiltration into OM fat was mainly observed in a subgroup in whom obesity was associated with impaired glucose homeostasis. CONCLUSIONS: Preferential macrophage infiltration into OM fat is a general phenomenon exaggerated by central obesity, potentially linking central adiposity with increased risk of diabetes and coronary heart disease. FAU - Harman-Boehm, Ilana AU - Harman-Boehm I AD - Department of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel. FAU - Bluher, Matthias AU - Bluher M FAU - Redel, Henry AU - Redel H FAU - Sion-Vardy, Netta AU - Sion-Vardy N FAU - Ovadia, Shira AU - Ovadia S FAU - Avinoach, Eliezer AU - Avinoach E FAU - Shai, Iris AU - Shai I FAU - Kloting, Nora AU - Kloting N FAU - Stumvoll, Michael AU - Stumvoll M FAU - Bashan, Nava AU - Bashan N FAU - Rudich, Assaf AU - Rudich A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070320 PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (RNA, Messenger) RN - 81627-83-0 (Macrophage Colony-Stimulating Factor) SB - IM MH - Adult MH - Aged MH - Biopsy MH - Body Mass Index MH - Cell Movement/immunology MH - Chemokine CCL2/genetics MH - Cohort Studies MH - Comorbidity MH - Female MH - Humans MH - Macrophage Colony-Stimulating Factor/genetics MH - Macrophages/*cytology/immunology MH - Male MH - Middle Aged MH - Obesity/*immunology/*mortality/pathology MH - Omentum/*cytology/immunology MH - RNA, Messenger/metabolism MH - Subcutaneous Fat, Abdominal/*cytology/immunology EDAT- 2007/03/22 09:00 MHDA- 2007/07/19 09:00 CRDT- 2007/03/22 09:00 PHST- 2007/03/22 09:00 [pubmed] PHST- 2007/07/19 09:00 [medline] PHST- 2007/03/22 09:00 [entrez] AID - jc.2006-1811 [pii] AID - 10.1210/jc.2006-1811 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2007 Jun;92(6):2240-7. doi: 10.1210/jc.2006-1811. Epub 2007 Mar 20.